Leptin has been pointed out as a necessary factor for OA development in in vivo animal models of obesity, while studies on patients support its role in human OA, with a direct correlation between serum leptin levels and diminished cartilage thickness [39, 40]. This evidence concerns the gene LEP and obesity disorder.